Lana Sinichkina, Kateryna Oliinyk and Yevgeniya Ocheretko discuss how the recent settlement between Gilead and Ukraine's Ministry of Health could promote earlier market access in the country.
Lana Sinichkina, Kateryna Oliinyk, Yevgeniya Ocheretko
Advertisement
Lana Sinichkina is Partner, Kateryna Oliinyk is Counsel, andYevgeniya Ocheretko is Associate, all at Arzinger, Ukraine.
Articles by Lana Sinichkina, Kateryna Oliinyk, Yevgeniya Ocheretko
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
AI has Redefined Healthcare Communication — and There’s No Opting Out
2
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
3
Novo Nordisk Signs Deal with Hims & Hers
4
FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer
5